| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
chromodomain helicase DNA binding protein 8 | 0.656 | 0.577 | 1.00 |
|
phenotype | 0.110 | None | 1.000 | 4 | 1 | 2012 | 2020 | ||||||||
|
DEP domain containing 5, GATOR1 subcomplex subunit | 0.631 | 0.538 | 0.12 |
|
phenotype | 0.150 | None | 1.000 | 4 | 4 | 2013 | 2020 | ||||||||
|
carnitine O-acetyltransferase | 0.656 | 0.577 | 9.5E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2020 | 2020 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
phenotype | 0.200 | None | 0.957 | 0 | 3 | 2012 | 2020 | ||||||||
|
contactin associated protein 2 | 0.530 | 0.846 | 2.9E-09 |
|
phenotype | 0.200 | None | 1.000 | 0 | 0 | 2008 | 2020 | ||||||||
|
laminin subunit alpha 2 | 0.553 | 0.692 | 2.4E-47 |
|
phenotype | 0.110 | None | 1.000 | 0 | 1 | 2020 | 2020 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
phenotype | 0.440 | strong | 1.000 | 0 | 0 | 1998 | 2020 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.500 | None | 0.952 | 0 | 0 | 1997 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 1 | 0.477 | 0.808 | 1.00 |
|
phenotype | 0.200 | None | 0.932 | 0 | 15 | 2002 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 9 | 0.543 | 0.615 | 4.8E-19 |
|
phenotype | 0.150 | None | 1.000 | 0 | 0 | 2005 | 2020 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
phenotype | 0.130 | None | 1.000 | 0 | 0 | 2019 | 2020 | ||||||||
|
NK6 homeobox 2 | 0.695 | 0.500 | 2.9E-02 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2020 | 2020 | ||||||||
|
DNA polymerase gamma, catalytic subunit | 0.457 | 0.846 | 2.1E-09 |
|
phenotype | 0.430 | None | 1.000 | 76 | 11 | 2001 | 2019 | ||||||||
|
potassium voltage-gated channel subfamily Q member 2 | 0.537 | 0.654 | 1.00 |
|
phenotype | 0.500 | None | 1.000 | 23 | 16 | 1984 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 4 subunit | 0.492 | 0.808 | 8.5E-05 |
|
phenotype | 0.440 | None | 1.000 | 9 | 1 | 1999 | 2019 | ||||||||
|
methyl-CpG binding protein 2 | 0.414 | 0.846 | 0.89 |
|
phenotype | 0.500 | None | 0.923 | 6 | 6 | 2000 | 2019 | ||||||||
|
major facilitator superfamily domain containing 8 | 0.682 | 0.231 | 2.5E-12 |
|
phenotype | 0.110 | None | 1.000 | 4 | 3 | 2009 | 2019 | ||||||||
|
potassium sodium-activated channel subfamily T member 1 | 0.610 | 0.308 | 2.8E-05 |
|
phenotype | 0.140 | None | 1.000 | 3 | 1 | 2015 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
phenotype | 0.140 | None | 0.857 | 3 | 1 | 2006 | 2019 | ||||||||
|
TBC1 domain family member 24 | 0.530 | 0.808 | 1.3E-08 |
|
phenotype | 0.180 | None | 1.000 | 2 | 8 | 2014 | 2019 | ||||||||
|
actin like 6B | 0.656 | 0.462 | 2.8E-04 |
|
phenotype | 0.400 | strong | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
SRY-box transcription factor 4 | 0.489 | 0.808 | 0.93 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
NPR2 like, GATOR1 complex subunit | 0.644 | 0.462 | 0.39 |
|
phenotype | 0.120 | None | 1.000 | 0 | 0 | 2016 | 2019 | ||||||||
|
choline O-acetyltransferase | 0.520 | 0.808 | 5.6E-11 |
|
phenotype | 0.410 | None | 1.000 | 0 | 0 | 2010 | 2019 | ||||||||
|
proline rich transmembrane protein 2 | 0.448 | 0.808 | 0.58 |
|
phenotype | 0.200 | None | 1.000 | 0 | 0 | 1999 | 2019 |